Claassen I - Search Results

1

Feasibility study to evaluate the correlation between results of a candidate in vitro assay and established in vivo assays for potency determination of Newcastle disease vaccines.

Claassen I, Maas R, Daas A, Milne C. Claassen I, et al. Pharmeuropa Bio. 2003 Jul;2003(1):51-66. Pharmeuropa Bio. 2003. PMID: 14563308

2

Correlation of haemagglutinin-neuraminidase and fusion protein content with protective antibody response after immunisation with inactivated Newcastle disease vaccines.

Maas RA, Komen M, van Diepen M, Oei HL, Claassen IJ. Maas RA, et al. Among authors: claassen ij. Vaccine. 2003 Jul 4;21(23):3137-42. doi: 10.1016/s0264-410x(03)00249-4. Vaccine. 2003. PMID: 12804840

3

Validation of a candidate in vitro potency assay for inactivated Newcastle disease vaccines.

Maas R, Komen M, Oei H, Claassen I. Maas R, et al. Among authors: claassen i. Dev Biol (Basel). 2002;111:163-9. Dev Biol (Basel). 2002. PMID: 12678237

4

Antigen content of inactivated Newcastle disease oil emulsion vaccines as an in vitro indicator of potency.

Maas R, van Diepen M, Komen M, Oei H, Claassen I. Maas R, et al. Among authors: claassen i. Dev Biol (Basel). 2002;111:313-8. Dev Biol (Basel). 2002. PMID: 12678255

5

Validation study to evaluate the reproducibility of a candidate in vitro potency assay of newcastle disease vaccines and to establish the suitability of a candidate biological reference preparation.

Claassen I, Maas R, Oei H, Daas A, Milne C. Claassen I, et al. Pharmeuropa Bio. 2004 Dec;2004(1):1-15. Pharmeuropa Bio. 2004. PMID: 15659281

6

Antigen quantification as in vitro alternative for potency testing of inactivated viral poultry vaccines.

Maas RA, de Winter MP, Venema S, Oei HL, Claassen IJ. Maas RA, et al. Among authors: claassen ij. Vet Q. 2000 Oct;22(4):223-7. doi: 10.1080/01652176.2000.9695063. Vet Q. 2000. PMID: 11087135 Free article.

7

Quantification of infectious bursal disease viral proteins 2 and 3 in inactivated vaccines as an indicator of serological response and measure of potency.

Maas R, Venema S, Kant A, Oei H, Claassen I. Maas R, et al. Among authors: claassen i. Avian Pathol. 2004 Apr;33(2):126-32. doi: 10.1080/03079450310001652121. Avian Pathol. 2004. PMID: 15276978 Clinical Trial.

8

Replacement of primary chicken embryonic fibroblasts (CEF) by the DF-1 cell line for detection of avian leucosis viruses.

Maas R, van Zoelen D, Oei H, Claassen I. Maas R, et al. Among authors: claassen i. Biologicals. 2006 Sep;34(3):177-81. doi: 10.1016/j.biologicals.2005.09.002. Epub 2005 Oct 28. Biologicals. 2006. PMID: 16257542

9

Efficacy of inactivated infectious bursal disease (IBD) vaccines: comparison of serology with protection of progeny chickens against IBD virus strains of varying virulence.

Maas RA, Venema S, Oei HL, Pol JM, Claassen IJ, Huurne AA. Maas RA, et al. Among authors: claassen ij. Avian Pathol. 2001 Aug;30(4):345-54. doi: 10.1080/03079450120066359. Avian Pathol. 2001. PMID: 19184920

10

Silent spread of highly pathogenic Avian Influenza H5N1 virus amongst vaccinated commercial layers.

Poetri ON, Van Boven M, Claassen I, Koch G, Wibawan IW, Stegeman A, Van den Broek J, Bouma A. Poetri ON, et al. Among authors: claassen i. Res Vet Sci. 2014 Dec;97(3):637-41. doi: 10.1016/j.rvsc.2014.09.013. Epub 2014 Sep 19. Res Vet Sci. 2014. PMID: 25301756 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters